Dr. Wallace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-834-7072
Summary
- Dr. James Wallace is a Medical Oncologist with a specialty in Geriatric Oncology. He received his undergraduate degree at Princeton University, Medical Degree from The University of Vermont, and Hematology Oncology, Ethics, and Geriatrics Fellowships at University of Chicago. He has been in practice 15 years. He participates in clinical research and is active faculty teaching students at the University of Chicago.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2005 - 2008- University of ChicagoFellowship, Geriatric Medicine (Internal Medicine), 2006 - 2007
Boston University Medical CenterResidency, Internal Medicine, 2002 - 2005
University of Vermont College of MedicineClass of 2002
Princeton UniversityA.B., Ecology and Evolutionary Biology , 1990 - 1994
Certifications & Licensure
IL State Medical License 2005 - 2026
IN State Medical License 2008 - 2025- American Board of Internal Medicine Geriatric Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 385 citationsRandomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic CancerDaniel V.T. Catenacci, Melissa R. Junttila, Theodore Karrison, Nathan Bahary, M. N. Horiba
Journal of Clinical Oncology. 2015-12-20 - 51 citationsProstate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry P Simko
NPJ Digital Medicine. 2022-06-08 - 76 citationsGemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II ConsortiumHedy L. Kindler, Kristen Wroblewski, James A. Wallace, Michael J. Hall, Gershon Y. Locker
Investigational New Drugs. 2012-02-01
Press Mentions
Living with Stage 3 Lung Cancer in Your 80s and 90sApril 26th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
